Skip to main content
. 2023 Oct 12;14:1169292. doi: 10.3389/fphar.2023.1169292

FIGURE 4.

FIGURE 4

Data analysis of the HAMA-14 scores (XYS combined with anxiolytics vs. anxiolytics alone). (A) Before eliminating sources of heterogeneity. (B) After eliminating sources of heterogeneity. (C) Trial sequential analysis. The annotations of the red line and blue line in TSA are the same as those in Figure 3.